← Open Payments lookup

MARY KATHRYN CHESTANG: Open Payments

NPI 1205463338 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,496 in 115 payments from 21 companies in 2025. Trend: 2023 $1,929 · 2024 $2,252 · 2025 $2,496

Food & beverage: $2,496
CompanyPaymentsAmount
GlaxoSmithKline, LLC.16$353
Mallinckrodt Hospital Products Inc.12$260
GENZYME CORPORATION10$236
Amgen Inc.15$225
AstraZeneca Pharmaceuticals LP9$203
Boehringer Ingelheim Pharmaceuticals, Inc.7$168
Philips North America LLC8$149
Grifols USA, LLC5$124
Merck Sharp & Dohme LLC6$123
Takeda Pharmaceuticals U.S.A., Inc.3$90

Products named: TEZSPIRE, DUPIXENT, ACTHAR, TRELEGY ELLIPTA, NUCALA, Vest Therapy Und, Prolastin-C Liquid, ZERBAXA.

Industry payments across AL — which companies pay providers there.